Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2007 by Hartford Hospital.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Hartford Hospital
ClinicalTrials.gov Identifier:
NCT00282620
First received: January 25, 2006
Last updated: November 16, 2007
Last verified: March 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2008
  Estimated Primary Completion Date: No date given